Presentation ACC 2026 Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis Presenter: Nicholas Marston March 30, 2026
Presentation ACC 2026 Evolocumab in Patients without Known Atherosclerosis and with Diabetes: Secondary Analysis from VESALIUS-CV Presenter: Nicholas Marston March 28, 2026
Presentation ACC 2017 Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017